Eagles' Jalen Hurts expected to miss season over blood clots - ESPN

Jalen Hurts is expected to miss the rest of the season after doctors discovered multiple blood clots in the Philadelphia Eagles quarterback's lungs, sources told NFL Network's Ian Rapoport and ESPN's Adam Schefter.

Hurts will undergo treatment involving blood thinners that is expected to sideline the three-time Pro Bowler for at least three months, sources informed of the diagnosis told Rapoport and Schefter.

Hurts' agent, Nicole Lynn, and the Eagles released a statement Monday detailing Hurts' condition. Lynn and the Eagles said Hurts has deep vein thrombosis and bilateral pulmonary emboli, meaning a blood clot traveled from his legs to his lungs.

https://t.co/aInIuUYiQJ

Hurts is «clinically stable and has no significant functional limitations,» according to the statement, but will not be allowed to participate in football activities while on anticoagulation medication.

«Jalen's prognosis is very good, and we expect a full recovery,» the statement said. «We anticipate that he will have the opportunity to resume contact football activities when off the blood thinners. In the meantime, he will remain active around the team and continue to condition. More importantly, we anticipate that he will have no long-term effects.»

Hurts was initially diagnosed with what was described as a superficial blood clot in his calf. That diagnosis occurred in London before the Eagles' Week 5 game against the Jacksonville Jaguars at Tottenham Hotspur Stadium. Hurts played in that game — a 19-17 loss for the Eagles — despite the initial diagnosis and attempted 40 passes.

Sources told Rapoport that Hurts was in the hospital in London until 4 a.m. on the morning of the game. He did not sleep the night before the game because he was told that